Logo

American Heart Association

  2
  0


Final ID: MDP349

A Novel Cardiac Simulator "ped UT-Heart" to Support Decision-Making in Surgical Procedures for Complex Congenital Heart Disease

Abstract Body (Do not enter title and authors here):
Background: To support the surgical decision-making for complex congenital heart disease (CHD), a novel computer-based cardiac simulator called "ped UT-Heart" has been developed, in which a patient-specific finite element model simulates cardiac functions and predicts hemodynamics of different virtual surgeries.
Objective: To validate the accuracy, usefulness, and safety of the “ped UT-Heart“ simulation system.
Methods: First, retrospective validation studies of pre- and post-operative simulation (n=10) were performed by comparing virtual simulation data with real patient catheter data. Subsequently, a single-arm, prospective, multicenter clinical study (jRCTs052210139) was conducted in 16 patients with complex CHD (Table 1). The primary endpoint was defined as an overall rating of essential or very useful on a 5-point Likert scale.
Results: Pre- and post-operative simulation data correlated well with patient catheter data (Figure 1). In the clinical trial, four patients were excluded due to delayed surgery, and the remaining 12 patients (median age, 2y8m) were assessed for usefulness. There were no adverse events associated with the simulation system. Nine of the twelve patients (>60%) were rated as “Essential” or “Very useful“, and the lower limit of the 95% CI was 42.8% (>30%), indicating that the results met the primary endpoint. As a representative case (ccTGA, 5y), the surgeon selected a double switch operation with VSD augmentation according to the post-operative simulation (Figure 2). The patient did well after the surgery with no significant hemodynamic problems.
Conclusions: The "ped UT-Heart" is a safe, reliable, and useful cardiac simulator for supporting decisions of surgical procedures in complex CHD.
  • Shiraishi, Isao  ( NATIONAL CARDIOVASCULAR CENTER , Suita , Osaka , Japan )
  • Kurosaki, Kenichi  ( NATIONAL CARDIOVASCULAR CENTER , Suita , Osaka , Japan )
  • Iwai, Shigemitsu  ( NATIONAL CARDIOVASUCLAR CENTER , Suita , Osaka , Japan )
  • Washio, Takumi  ( The University of Tokyo , Kashiwa , Chiba , Japan )
  • Sugiura, Seiryo  ( The University of Tokyo , Kashiwa , Chiba , Japan )
  • Hisada, Toshiaki  ( The University of Tokyo , Kashiwa , Chiba , Japan )
  • Author Disclosures:
    Isao Shiraishi: DO have relevant financial relationships ; Consultant:Japan Medical Device:Active (exists now) ; Research Funding (PI or named investigator):crossMedical:Past (completed) ; Research Funding (PI or named investigator):Japan Medical Device:Active (exists now) | Kenichi Kurosaki: No Answer | Shigemitsu Iwai: DO NOT have relevant financial relationships | Takumi Washio: DO NOT have relevant financial relationships | Seiryo Sugiura: No Answer | Toshiaki Hisada: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pediatric Cardiac Surgery and Transplantation

Saturday, 11/16/2024 , 02:50PM - 04:15PM

Moderated Digital Poster Session

You have to be authorized to contact abstract author. Please, Login
Not Available